Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Association of Family History of Cardiovascular Diseases in Boys Aged 12-13 Years with Structural and Functional Indicators of the Left Ventricle and Arterial Stiffness in the Age of 43-46 Years (Results of 32-Year Prospective Follow-up)

https://doi.org/10.20996/1819-6446-2019-15-6-854-863

Full Text:

Abstract

Aim. To evaluate the association of Family History (FH) of cardiovascular diseases (CVD) in boys aged 12-13 years with the development of structural and functional changes in the left ventricle and stiffness of the main arteries in adulthood (43-46 years old) according to prospective study.

Material and methods. For the initial examination, boys were selected whose parents suffered from CVD at a young age or died prematurely from them (risk group). The comparison group was formed from a population sample of boys of a similar age without FH of CVD. The examination included a survey on a standard questionnaire, measurement of anthropometric indicators, blood pressure (BP), pulse counting, determination of the blood lipid spectrum. The intima-media complex thickness (IMT) of the common carotid arteries was measured; echocardiography and applanation tonometry were performed.

Results. The group with FH of CVD significantly (p<0.05) differed in childhood in terms of the body mass index (BMI) (18.8 vs 17.6 kg/m2), systolic BP (SBP) (117 vs 107 mm Hg), diastolic BP (DBP) (67 vs 56 mm Hg), average BP (81.8 vs 72.7 mm Hg) and triglycerides (0.79 vs 0.58 mmol/L). In adulthood, increased total cholesterol (TC) level (6.3 vs 5.8 mmol/L; p=0.036) and other indicators of atherogenesis were revealed in the risk group. The risk of fatal outcomes from CVD in the next 10 years in men with a family history of CVD in childhood was significantly higher compared to the control group (1.94 vs. 1.28; p <0.001). The main contribution to the total risk of fatal CVD in middle-aged men was made by TC and smoking. In the group with FH of CVD, higher stiffness of the arteries in adulthood was observed. There were found significant (p=0.002) intergroup differences in the IMT (0.73 vs 0.63 mm). A statistically significant positive relationship between BMI and some structural and functional indicators of the left ventricle and stiffness indicators of the main arteries was revealed. DBP and mean BP in childhood are associated with arterial stiffness in adulthood according to the parameters of central SBP and central DBP. BMI in boys is the most significant predictor for most structural and functional indicators of LV myocardial hypertrophy, in particular, LV myocardial mass (private R2=0.140) and interventricular septum thickness (R2=0.164; p=0.001), and arterial stiffness by central DBP parameter (R2=0.043; p=0.024) in adulthood. The risk of increased IMT development in males in adulthood with FH of CVD is 6.1 times higher than that of their peers without FH.

Conclusion. FH of CVD revealed in childhood in males is a risk factor for the development of early atherosclerosis and, due to its ease of detection, can be used as one of the criteria for the formation of high-risk groups for the purpose of primary prevention.

About the Authors

O. Yu. Isaykina
National Medical Research Center for Preventive Medicine
Russian Federation

Olesya Yu. Isaykina – MD, PhD, Senior Researcher, Laboratory for the Use of Outpatient Diagnostic Methods in the Prevention of Chronic Non-Communicable Diseases in the Health System

Petroverigsky per. 10, Moscow, 101000



V. B. Rozanov
National Medical Research Center for Preventive Medicine
Russian Federation

Vyatcheslav B. Rozanov – MD, PhD, Leading Researcher, Laboratory for the Prevention of Chronic Non-Communicable Diseases in Children and Adolescents, Department of Primary Prevention of Chronic Non-Communicable Diseases in the Health System

Petroverigsky per. 10, Moscow, 101000



A. A. Aleksandrov
National Medical Research Center for Preventive Medicine
Russian Federation

Аleksander А. Aleksandrov – MD, PhD, Professor, Head of the Laboratory for the Prevention of Chronic Non-Communicable Diseases in Children and Adolescents, Department of Primary Prevention of Chronic Non-Communicable Diseases in the Health System

Petroverigsky per. 10, Moscow, 101000



I. V. Leontyeva
Research Clinical Institute of Pediatrics, Pirogov Russian National Research Medical University
Russian Federation

Irina V. Leontyeva – MD, PhD, Professor, Chief Researcher, Department of Pediatric Cardiology and Arrhythmology, Research Clinical Institute of Pediatrics

Ostrovityanova ul. 1, Moscow, 117997



M. B. Kotova
National Medical Research Center for Preventive Medicine
Russian Federation

Marina B. Kotova – PhD (Psychology), Leading Researcher, Laboratory for the Prevention of Chronic Non-Communicable Diseases in Children and Adolescents, Department of Primary Prevention of Chronic Non-Communicable Diseases in the Health System

Petroverigsky per. 10, Moscow, 101000



E. I. Ivanova
National Medical Research Center for Preventive Medicine
Russian Federation

Elena I. Ivanova – Researcher, Laboratory for the Prevention of Chronic Non-Communicable Diseases in Children and Adolescents, Department of Primary Prevention of Chronic Non-Communicable Diseases in the Health System

Petroverigsky per. 10, Moscow, 101000



References

1. Boytsov S.A., Deev A.D., Shalnova S.A. Mortality and risk factors for non-communicable diseases in Russia: Specific features, trends, and prognosis. Ter Arkhiv. 2017;1:5-13 (In Russ.) DOI:10.17116/terarkh20178915-13.

2. Wang T.J., Gona P., Larson M.G. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med. 2006;355:2631-9. DOI: 10.1056/NEJMoa055373.

3. Piepoli M.F., Hoes A.W., Agewall S., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016;37(29):2315-81. DOI:10.1093/eurheartj/ehw106.

4. Kullo I.J., Malik A.R. Arterial Ultrasonography and Tonometry as Adjuncts to Cardiovascular Risk Stratification. JACC. 2007;49:1413-126. DOI:10.1016/j.jacc.2006.11.039.

5. Smirnova M.D., Ageev F.T. Left ventricular hypertrophy: prognostic value, pathogenesis, possible remodeling: focusing on angiotensin receptor antagonists. Cardiovascular Therapy and Prevention. 2007;6(6):109-16. (In Russ.)

6. Budhwani N., Patel S., Dwyer E.M. Electrocardiographic diagnosis of left ventricular hypertrophy: the effect of left ventricular wall thickness, size and mass on the specific criteria for left ventricular hypertrophy. Am Heart J. 2005;149(4):709-14. DOI:10.1016/j.ahj.2004.07.040.

7. Kannel W.B. Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens. 2000;14:83-90. DOI:10.1038/sj.jhh.1000949.

8. Verdecchia P. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens. 2003;16(11):895-9. DOI:10.1016/S0895-7061(03)01018-5.

9. Uskova O.V., Sobolev K.O., Storozhakov G.I. Left Ventricular Hypertrophy: Diagnosis, Consequences, and Prognosis. Lechebnoye Delo. 2012;2:4-8 (In Russ.)

10. Townsend R.R., Wilkinson I.B., Schiffrin E.L., et al. American Heart Association Council on Hypertension. Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness. A Scientific Statement from the American Heart Association. J Hypertension. 2015;66(3):698-722. DOI:10.1161/HYP.0000000000000033.

11. Pauca A.L., O’Rourke M.F., Kon N.D. Prospective Evaluation of a Method for estimating ascending aortic pressure from the radial artery pressure wave form. Hypertension. 2001;38:932-7. DOI:10.1161/hy1001.096106.

12. Van Bortel L.M., Laurent S., Boutouyrie P., et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulsewave velocity. J.Hypertens. 2012;30:445-8. DOI:10.1097/hjh.0b013e32834fa8b0.

13. Pai P.K., Nagendra K., Ramaraj S.M. A study of lipid profile and carotid artery and abdominal aorta intimamedia thickness in children with parental history of premature ischemic heart disease. Int J Contemp Pediatr. 2018;5(3):1013-8.

14. Davis P.H., Dawson J.D., Riley W.A., Lauer R.M. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: the Muscatine Study. Circ. 2001;104:2815-9.DOI:10.1161/hc4601.099486.

15. Li S., Chen W., Srinivasan S.R. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa heart study. JAMA. 2003;290:2271-6. DOI:10.1001/jama.290.17.2271.

16. Järvisalo M.J., Jartti L., Näntö-Salonen K., et al. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circ. 2001;104(24):2943-7. DOI:10.1161/hc4901.100522.

17. Lorenz M.W., Markus H.S., Bots M.L., et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation. 2007;115(4):459-67. DOI:10.1161/CIRCULATIONAHA.106.628875.

18. Protogerou A.D., Papaioannou T.G., Blacher J., et al.Central blood pressure: do we need them in the management of cardiovascular disease? Is it a feasible therapeutic target? J Hypertens. 2007;25(2):265-72. DOI:10.1097/HJH.0b013e3280114f23.

19. Panagiotakos D.B., Pitsavos C., Chrysohoou C., et al. Risk Stratification of Coronary Heart Disease in Greece: final Results from the CARDIO2000. Epidemiological Study. Prev Med. 2002;35(6):54856. DOI:10.1006/pmed.2002.1108.

20. Taira K., Bujo H., Kobayashi J., et al. Positive family history for coronary heart disease and ‘midband lipoproteins’ are potential risk factors of carotid atherosclerosis in familial hypercholesterolemia. Atherosclerosis. 2002;160(2):391-7. DOI:10.1016/s0021-9150(01)00577-9.


For citation:


Isaykina O.Y., Rozanov V.B., Aleksandrov A.A., Leontyeva I.V., Kotova M.B., Ivanova E.I. Association of Family History of Cardiovascular Diseases in Boys Aged 12-13 Years with Structural and Functional Indicators of the Left Ventricle and Arterial Stiffness in the Age of 43-46 Years (Results of 32-Year Prospective Follow-up). Rational Pharmacotherapy in Cardiology. 2019;15(6):854-863. (In Russ.) https://doi.org/10.20996/1819-6446-2019-15-6-854-863

Views: 35


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)